Caplin Point Laboratories Ltd (CAPLIPOINT) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 640544, "name": "Caplin Point Lab", "stock_name": "Caplin Point Lab", "full_name": "Caplin Point Laboratories Ltd", "name_url": "stocks-analysis/caplin-point-lab", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "2,632.35", "chg": -76.45, "chgp": "-2.82%", "dir": -1, "prev_price": "2,708.80", "mcapval": "20,340.00 Cr", "mcap": "Small Cap", "scripcode": 524742, "symbol": "CAPLIPOINT", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE475E01026", "curr_date": "Oct 01, 03:30 PM", "curr_time": "12:07 PM", "last_traded_at": "Oct 01, 03:30 PM IST", "bse_nse_vol": "1.61 lacs", "exc_status": "Active", "traded_date": "Oct 01, 2026", "traded_date_str": "2026 10 01", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/caplin-point-lab-640544-0&utm_source=Website_LockedLinks_StockPageName", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Caplin Point Laboratories Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-buy-4212343", "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/CaplinPointLabo_mojoScore_4212343.png", "date": "2026-10-03 10:10:31", "description": "Caplin Point Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 21 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 October 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Caplin Point Laboratories Gains 3.20%: 4 Key Factors Driving the Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-gains-320-4-key-factors-driving-the-rally-4206104", "imagepath": "", "date": "2026-09-26 16:04:37", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>21 Sep:</strong> Technical momentum shifts signal bullish outlook</p>\n <p><strong>22 Sep:</strong> Upgraded to Buy on strong technical and financial performance</p>\n <p><strong>24 Sep:</strong> Hits new 52-week high at Rs.2,990.60 and all-time high</p>\n <p><strong>25 Sep:</strong> Week closes at Rs.2,835.80 (-1.05% on day)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,747.85</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs..." }, { "title": "Broad-Based Technical Strength Lifts Caplin Point Laboratories Ltd to 52-Week High of Rs 2990.6", "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-hits-new-52-week-high-at-rs-29906-4203252", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CaplinPointLabo_priceRelatedfactors_4203252.png", "date": "2026-09-24 09:45:35", "description": "With every major technical indicator aligned to the upside, Caplin Point Laboratories Ltd surged to a fresh 52-week high of Rs 2990.6 on 24 Sep 2026, marking a significant milestone in its price momentum despite a broadly weak market backdrop." }, { "title": "Caplin Point Laboratories Ltd Hits All-Time High of Rs 2,966.50 as Momentum Builds Across Timeframes", "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-hits-all-time-high-amid-strong-financial-performance-4203191", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CaplinPointLabo_priceRelatedfactors_4203191.png", "date": "2026-09-24 09:32:53", "description": "Extending its winning streak to seven consecutive sessions, Caplin Point Laboratories Ltd surged 6.28% on 24 Sep 2026 to close at Rs 2,966.50, just 0.81% shy of its 52-week high. This rally has propelled the stock to a fresh all-time high, significantly outpacing the Sensex which declined 0.75% on the same day." }, { "title": "Caplin Point Laboratories Upgraded to Buy on Strong Technical and Financial Performance", "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-upgraded-to-buy-on-strong-technical-and-financial-performance-4200640", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CaplinPointLabo_mojoScore_4200640.png", "date": "2026-09-22 08:35:24", "description": "Caplin Point Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 21 September 2026, comes amid robust quarterly results, a bullish technical outlook, and consistent long-term returns that have outpaced the broader market." }, { "title": "Caplin Point Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-technical-momentum-shifts-signal-bullish-outlook-4199069", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CaplinPointLabo_technicaldot_4199069.png", "date": "2026-09-21 08:02:10", "description": "Caplin Point Laboratories Ltd has demonstrated a significant shift in price momentum, supported by a series of bullish technical indicators across multiple timeframes. The pharmaceutical and biotechnology small-cap stock has seen its technical trend upgrade from mildly bullish to bullish, reflecting growing investor confidence and positive price action in recent sessions." }, { "title": "Caplin Point Laboratories Ltd’s Mixed Week: -0.25% Price Change Amid Technical Shift", "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltds-mixed-week--025-price-change-amid-technical-shift-4198400", "imagepath": "", "date": "2026-09-19 16:03:24", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>15 Sep:</strong> Stock plunges 6.68% following downgrade to Hold</p>\n <p><strong>16 Sep:</strong> Technical momentum shifts amid market volatility</p>\n <p><strong>17 Sep:</strong> Modest gains of 0.45% as technical indicators show mixed signals</p>\n <p><strong>18 Sep:</strong> Strong rebound with 5.87% gain, closing near weekly highs</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,754.75</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"sta..." }, { "title": "Caplin Point Laboratories Downgraded to Hold Amid Mixed Technical and Valuation Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-4194556", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CaplinPointLabo_mojoScore_4194556.png", "date": "2026-09-16 08:56:46", "description": "Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 15 Sep 2026. This adjustment reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite robust financial performance and consistent returns, evolving technical indicators and valuation concerns have tempered the outlook, prompting a more cautious stance among investors." }, { "title": "Caplin Point Laboratories Ltd: Technical Momentum Shifts Amid Market Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-technical-momentum-shifts-amid-market-volatility-4194139", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CaplinPointLabo_technicaldot_4194139.png", "date": "2026-09-16 08:05:47", "description": "Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a sharp 6.68% decline in the latest trading session, the stock’s year-to-date return remains robust at 39.63%, outperforming the Sensex by a wide margin." } ], "total": 692, "sid": "640544", "stock_news_url": "https://www.marketsmojo.com/news/caplin-point-laboratories-640544" }, "announcements": [ { "caption": "Closure of Trading Window", "datetime": "28-Sep-2026", "details": "Intimation of Closure of Trading Window for the quarter and half year ended September 30 2026 commencing from October 01 2026.", "source": "BSE" }, { "caption": "Clarification sought from Caplin Point Laboratories Ltd", "datetime": "25-Sep-2026", "details": "The Exchange has sought clarification from Caplin Point Laboratories Ltd on September 25 2026 with reference to Movement in Volume.<BR><BR>The reply is awaited.", "source": "BSE" }, { "caption": "Clarification With Respect To Volume Movement", "datetime": "25-Sep-2026", "details": "Clarification with respect to Volume Movement", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Caplin Point Laboratories Ltd has declared <strong>200%</strong> dividend, ex-date: 18 Sep 26", "dt": "2026-09-18", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Caplin Point Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 19 Oct 16", "dt": "2016-10-19", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

21 Sep: Technical momentum shifts signal bullish outlook

22 Sep: Upgraded to Buy on strong technical and financial performance

24 Sep: Hits new 52-week high at Rs.2,990.60 and all-time high

25 Sep: Week closes at Rs.2,835.80 (-1.05% on day)

Read full news article

Broad-Based Technical Strength Lifts Caplin Point Laboratories Ltd to 52-Week High of Rs 2990.6

2026-09-24 09:45:35

With every major technical indicator aligned to the upside, Caplin Point Laboratories Ltd surged to a fresh 52-week high of Rs 2990.6 on 24 Sep 2026, marking a significant milestone in its price momentum despite a broadly weak market backdrop.

Read full news article

Caplin Point Laboratories Ltd Hits All-Time High of Rs 2,966.50 as Momentum Builds Across Timeframes

2026-09-24 09:32:53

Extending its winning streak to seven consecutive sessions, Caplin Point Laboratories Ltd surged 6.28% on 24 Sep 2026 to close at Rs 2,966.50, just 0.81% shy of its 52-week high. This rally has propelled the stock to a fresh all-time high, significantly outpacing the Sensex which declined 0.75% on the same day.

Read full news article

Caplin Point Laboratories Upgraded to Buy on Strong Technical and Financial Performance

2026-09-22 08:35:24

Caplin Point Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 21 September 2026, comes amid robust quarterly results, a bullish technical outlook, and consistent long-term returns that have outpaced the broader market.

Read full news article

Caplin Point Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-09-21 08:02:10

Caplin Point Laboratories Ltd has demonstrated a significant shift in price momentum, supported by a series of bullish technical indicators across multiple timeframes. The pharmaceutical and biotechnology small-cap stock has seen its technical trend upgrade from mildly bullish to bullish, reflecting growing investor confidence and positive price action in recent sessions.

Read full news article

Caplin Point Laboratories Ltd’s Mixed Week: -0.25% Price Change Amid Technical Shift

2026-09-19 16:03:24

Key Events This Week

15 Sep: Stock plunges 6.68% following downgrade to Hold

16 Sep: Technical momentum shifts amid market volatility

17 Sep: Modest gains of 0.45% as technical indicators show mixed signals

18 Sep: Strong rebound with 5.87% gain, closing near weekly highs

Week Open

Rs.2,754.75

Week Close

Read full news article

Caplin Point Laboratories Downgraded to Hold Amid Mixed Technical and Valuation Signals

2026-09-16 08:56:46

Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 15 Sep 2026. This adjustment reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite robust financial performance and consistent returns, evolving technical indicators and valuation concerns have tempered the outlook, prompting a more cautious stance among investors.

Read full news article

Caplin Point Laboratories Ltd: Technical Momentum Shifts Amid Market Volatility

2026-09-16 08:05:47

Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a sharp 6.68% decline in the latest trading session, the stock’s year-to-date return remains robust at 39.63%, outperforming the Sensex by a wide margin.

Read full news article

View All News